Transplant Diagnostics are the tests that are carried out to check the compatibility between the organ donor and recipient before or after the organ transplant. According to the report that has been recently published by Market Research Future (MRFR), The Global Transplant Diagnostics Market is anticipated to expand at a noteworthy CAGR of 7.8 % during the forecast period of 2018-2023.
Global Transplant Diagnostics Market – Key Players
Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Becton Dickinson and Company (US), Abbott Laboratories Inc (US), CareDx (US), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), GenDx (Netherlands), Omixon Ltd. (UK), bioMérieux S.A. (France), Illumina, Inc. (US), Immucor Transplant Diagnostics, Inc (US), Affymetrix, Inc (US), Linkage Biosciences (US)
Industry Updates:
In May 2018, CareDx, a U.S.-based molecular diagnostics company, has announced the signing of licensing and commercialization agreement with Illumina, a provider of next-generation sequencing solutions. CareDx is now the exclusive worldwide distributor of Illumina’s TruSight HLA v1 and v2 product lines which will be used for bone marrow transplantation diagnostic testing and solid organ transplantation diagnostic testing.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1324
TAI Diagnostics which is US based company and develops non-invasive test to monitor patients’ health after they’ve got heart transplants, has scheduled to initiate selling their test early next year. They have generated about $13 million from their investors so far. The company is presently raising more money to supplement its $8.3 million Series A funding round. The extension could bring TAI’s total outside financing to $21 million, the startup’s test measures levels of cell-free DNA, genetic material released by the transplant recipient’s new heart that can enter the bloodstream, to assess whether they are in danger of rejecting the organ.
Thermo Fisher Scientific Acquires Linkage Bio: on July 2017 Thermo Fisher Scientific confirmed the company’s acquisition of Linkage Biosciences for an undisclosed amount, as a result of this acquisition Linkage Biosciences is now a part of Thermo Fisher’s transplant diagnostics business. The company based in South San Francisco, California. Benefits involved from the acquisition include a broader and deeper range of products, a continued commitment to innovation, and expanded support globally.
The business is extremely complementary to the company’s One Lambda tests, which regulate the compatibility of donors and recipients pre- and post-transplant. This acquisition further expands Thermo Fisher’s commitment of improving transplant patients’ quality of life over innovative high-quality products for the clinical and research segments of the transplant community.
Global Transplant Diagnostics Market – Segmentation
The Global Transplant Diagnostics Market has been segmented on the basis of product and services, screening type, organ type, application type and end-users. Based on product and services, the transplant diagnostics market is segmented into instruments, reagents and consumables, software and services. Based on screening type, the transplant diagnostics market is segmented into pre-transplant screening and post-transplant screening.
Based on organ type, the Transplant Diagnostics Market is segmented into kidney, pancreas, liver, heart, lungs and others. Based on application type, the transplant diagnostics market is segmented into research applications, diagnostic applications and others. Based on end-users, the transplant diagnostics market is segmented into commercial service providers, hospital and transplant centers, research laboratories and academic institutes, and others.
Browse Complete 100 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/transplant-diagnostics-market-1324
Global Transplant Diagnostics Market – Regional Analysis
Geographically, America dominated the global transplant diagnostics market. Increasing demand for the advanced techniques and diagnostic tools and higher healthcare expenditure are the major factor for the growth of the America market. Europe is the second largest transplant diagnostics market which is followed by Asia Pacific. Asia pacific is the fastest growing region for this market. Large population pole suffering from chronic diseases is the major driving factor for the Asia Pacific market.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
Your information will never be shared with any third party.